Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1Phase 2 1

Status

Completed 3Withdrawn 1

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Urinary Bladder Neoplasms 17Urethral Neoplasms 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Kidney Neoplasms 3Hodgkin Disease 3Congenital Abnormalities 3Carcinoma, Renal Cell 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Testicular Neoplasms 2Recurrence 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2

Interventions

Gemcitabine 24Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2pegfilgrastim 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Urethral Neoplasms × Methotrexate × Genitourinary × Clear all
NCT00003376 2023-06-22

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Eastern Cooperative Oncology Group

Phase 3 Completed
330 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003701 2023-06-15

Combination Chemotherapy in Treating Patients With Bladder Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
490 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT01639521 2014-01-29

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

University of Southern California

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00014274 2013-06-12

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Completed
238 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡